|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.52 EUR | -1.38% |
|
+6.78% | +12.17% |
| Jan. 16 | Health Care Up as Wegovy Pill Buoys Novo Nordisk -- Health Care Roundup | DJ |
| Jan. 16 | Bayer welcomes US Supreme Court decision to review Durnell case in Roundup litigation | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 47.31B | |||||
| 930B | |||||
| 527B | |||||
| 379B | |||||
| 371B | |||||
| 292B |
- Stock Market
- Equities
- BAYN Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
